September 11, 2014 3:38 pm
One of the most rapidly fast-tracked vaccines in history— an anti-Ebola “ChAd3” vaccine— just started clinical trial in humans, and may be done as soon as November. But a second fast-tracked anti-Ebola vaccine— called an “rVSV” vaccine— is hot on its heels.
September 4, 2014 3:05 pm
ZMapp, an experimental drug that may have already have saved a few patients in Africa, is the most effective anti-Ebola therapy yet, according to a recent Nature paper on rhesus macaques monkeys.
September 2, 2014 3:55 pm
Riken Center for Developmental Biology (CDB), the prominent Japan institute where Haruko Obokata was found to commit misconduct on stem cell papers, will be halved, according to a Riken representative.
August 28, 2014 8:30 am
At first blush it is a bit disingenuous, using beer waste as a base material for new bone. But that is exactly what a multidisciplinary team of researchers in Spain has come up with in a process for making the substrate material on which bone can be regenerated.
August 26, 2014 11:41 am
As, all around them, everyone from Derek Jeter to the Kennedy family was dousing themselves in ice water for the ALS “Ice Bucket Challenge,” Harvard researchers announced last week they may have found an ALS therapy— or two.
August 25, 2014 3:38 pm
A large new study found that when post-menopausal women stop physical activity, their odds of developing breast cancer rise. But, the study also found that breast cancer risk drops surprisingly rapidly after exercise starts.
August 21, 2014 2:44 pm
The birth control pill significantly affects ovarian reserve— or the number of immature eggs in a woman’s ovaries— which can be a predictor of future fertility, according to a team in Denmark.
August 14, 2014 11:10 am
Children with sensory processing disorder (SPD) have decreased white matter brain connections in sensory regions very different from those with autism, say researchers. Their study is the first to compare, and find critical differences in, brain connectivity in autism versus SPD versus controls.
August 11, 2014 2:26 pm
There have been stunning “firsts” in research on idiopathic pulmonary fibrosis (IPF), a mysterious disease that stiffens and stills the lungs, killing half its victims in three years. In May, results of Phase 3 clinical trials on the first two effective drugs for IPF were published in the New England Journal of Medicine (NEJM). And in June, the first paper explaining IPF was published in Science Translational Medicine.
July 29, 2014 3:33 pm
When cancers spread into the bloodstream, they often take on different characteristics, requiring different therapies. But it is hard to find these rare blood-borne cells. So, relapsed patients often do not get personalized care. Now, researchers have come up with a solution that zeros in on elusive circulating tumor cells (CTCs).
- 1 of 2
- next ›